MicroRNAs as Therapeutic Targets for Anticancer Drugs in Lung Cancer Therapy

Author(s): Yuan-Rong Liu, Ping-Yu Wang, Ning Xie*, Shu-Yang Xie*

Journal Name: Anti-Cancer Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Anti-Cancer Agents)

Volume 20 , Issue 16 , 2020

Become EABM
Become Reviewer


MicroRNAs (miRNAs) are short, non-coding RNA molecules that regulate gene expression by translational repression or deregulation of messenger RNAs. Accumulating evidence suggests that miRNAs play various roles in the development and progression of lung cancers. Although their precise roles in targeted cancer therapy are currently unclear, miRNAs have been shown to affect the sensitivity of tumors to anticancer drugs. A large number of recent studies have demonstrated that some anticancer drugs exerted antitumor activities by affecting the expression of miRNAs and their targeted genes. These studies have elucidated the specific biological mechanism of drugs in tumor suppression, which provides a new idea or basis for their clinical application. In this review, we summarized the therapeutic mechanisms of drugs in lung cancer therapy through their effects on miRNAs and their targeted genes, which highlights the roles of miRNAs as targets in lung cancer therapy.

Keywords: microRNAs, anticancer drugs, gene regulation, lung cancer, biological targets, cancer therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2020
Page: [1883 - 1894]
Pages: 12
DOI: 10.2174/1871520620666200615133011
Price: $95

Article Metrics

PDF: 7